Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8058 vs saline for MGD-associated dry eye (China phase 3)
CTR20210154Phase 3Completed
- Sponsor
- eVenus Pharmaceutical Laboratories
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perfluorohexyloctane in dry eye syndrome (DED), sponsored by eVenus Pharmaceutical Laboratories. Started Jan 2021; status: completed.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20210154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210154.